SOLICITATION NOTICE
66 -- DMT 204CM Pressure Myography System
- Notice Date
- 8/17/2016
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-CSB-HL-2016-265-KMA
- Archive Date
- 9/9/2016
- Point of Contact
- Kevin Alvarez,
- E-Mail Address
-
kevin.alvarez@nih.gov
(kevin.alvarez@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION. The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a noncompetitive sole source basis to DMT USA, Inc., 4474 Chattahoochee Plant Dr SE, Marietta, GA, 30067-4672, to procure a DMT 204CM pressure myography system that is required by the Sickle Cell Branch for studying ex vivo vascular smooth muscle and vascular endothelial function. BACKGROUND The goal of the Physiology Section of the Sickle Cell Branch is to investigate the physiologic sequelae associated with Sickle Cell Disease and related disorders involving aberrations in the production and function of hemoglobin. In addressing these issues, vascular function is considered a critical area of investigation, and is an emerging focus of the Ackerman laboratory. In order to investigate vascular function, specialized equipment is required to allow for experimentation and manipulation of ex vivo blood vessels. The DMT 204CM culture myograph system will allow for the study of ex vivo small resistance arteries and arterioles collected from mice, rats, and human subjects. DMT is currently the only manufacturer of a culture myography system that accommodates microvessels from mice and humans, allowing for study of vessels for 3-4 days. This feature will allow the lab to maximize the utility of vessel specimens we collect, both from their expensive murine models of sickle cell disease and alpha thalassemia, as well as from human subjects recruited with each of these conditions. Traditional myographs can only maintain a vessel for a few hours; having 3-4 days with the culture myograph system significantly enhances the amount of work that can be performed on each sample. Lastly, the stainless steel bath and chambers from DMT are unique to the industry and allow for incubation of drugs and media that cannot be used with plastic or glass chambers. The steel is also highly durable and will provide the laboratory the latitude necessary to carry out their complex experiments. PURPOSE The purpose of this acquisition is to procure a DMT 204CM pressure myography system. This pressure myography system will be used for studying ex vivo vascular smooth muscle and vascular endothelial function, particularly from small resistance arteries and arterioles collected from mice and human samples. PROCUREMENT The contractor shall provide the following: •Complete Culture Myograph System 204CM •MyoVIEW 4 for Culture system •Stage micrometer (Scale 1mm/0.01mm divisions) •Desktop computer (Preconfigured desktop, monitor, keyboard, mouse, and all required cables) JUSTIFICATION Through the market research performed, we have determined that DMT USA is the only vendor currently offering a pressure myography system that meets all of the capability requirements of the Sickle Cell Branch. In addition, the Sickle Cell Branch currently has collaborators at the University of Virginia who will be performing parallel experiments from a shared mouse colony. The University of Virginia currently operate a DMT 204CM system and because data will be shared back and forth between the two organizations, it is imperative that the lab purchase an identical machine in order to maintain continuity and integrity of the data. REGULATORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b), soliciting from a single source (for purchases not exceeding the simplified acquisition threshold) and only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION Industry Classification (NAICS) Code is 334516, Other Scientific and Technical Consulting Services, and the Small Business Size Standard is 1,000 employees. The acquisition is being conducted under FAR Part 13, Simplified Acquisition Procedures, therefore the requirements of FAR Part 6, Competitive Requirements, are not applicable (FAR Part 6.001). The resultant award will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-89 (August 15th, 2016). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by August 25, 2016 at 9:00AM EST and must reference synopsis number NHLBI-CSB-HL-2016-265-KMA. Responses shall be submitted to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch, 6701 Rockledge Drive, Room 6127, Bethesda, Maryland 20892-7902, Attention: Kevin Alvarez. Responses may be submitted electronically to kevin.alvarez@nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NHLBI/NHLBI-CSB-HL-2016-265-KMA/listing.html)
- Record
- SN04227725-W 20160819/160817234716-39aafdfc7896430866fd39778923b771 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |